Savara Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Savara Inc (SVRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 54.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 47.75K shares, a 6.41% increase year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 6.25K shares, a 98.66% decline year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 18.75K shares, a 26.83% decline year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 528.50K shares, a 182.40% increase from fiscal 2024.
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 187.15K shares, a 36.74% increase from fiscal 2023.
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 136.86K shares, a 87.50% decline from fiscal 2022.
- Savara Inc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.10M shares, a 8.14% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 47.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 54.00K shares 10-Q · filed 2026-08-11 | 72.75K shares derived: sum of 3 quarters · filed 2026-08-11 | 72.75K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 6.25K shares 10-Q · filed 2026-05-12 | 25.00K shares derived: sum of 2 quarters · filed 2026-05-12 | 25.00K shares derived: sum of 3 quarters · filed 2026-05-12 | 69.88K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 18.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 18.75K shares derived: sum of 2 quarters · filed 2026-03-13 | 63.63K shares derived: sum of 3 quarters · filed 2026-03-13 | 528.50K shares 10-K · filed 2026-03-13 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 44.88K shares derived: sum of 2 quarters · filed 2025-11-12 | 509.75K shares 10-Q · filed 2025-11-12 | 535.38K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 44.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 509.75K shares 10-Q · filed 2025-08-13 | 535.38K shares derived: sum of 3 quarters · filed 2025-08-13 | 631.59K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 464.87K shares 10-Q · filed 2025-05-13 | 490.50K shares derived: sum of 2 quarters · filed 2025-05-13 | 586.71K shares derived: sum of 3 quarters · filed 2025-05-13 | 652.02K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 25.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 121.84K shares derived: sum of 2 quarters · filed 2025-03-27 | 187.15K shares derived: sum of 3 quarters · filed 2025-03-27 | 187.15K shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 96.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 161.52K shares derived: sum of 2 quarters · filed 2024-11-12 | 161.52K shares 10-Q · filed 2024-11-12 | 167.38K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 65.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 65.31K shares 10-Q · filed 2024-08-12 | 71.17K shares derived: sum of 3 quarters · filed 2024-08-12 | 131.17K shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 5.86K shares derived: sum of 2 quarters · filed 2024-05-09 | 65.86K shares derived: sum of 3 quarters · filed 2024-05-09 | 84.92K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 5.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 65.86K shares derived: sum of 2 quarters · filed 2024-03-07 | 84.92K shares derived: sum of 3 quarters · filed 2024-03-07 | 136.86K shares 10-K · filed 2024-03-07 |
| 2023-09-30 | 60.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 79.06K shares derived: sum of 2 quarters · filed 2023-11-09 | 131.00K shares 10-Q · filed 2023-11-09 | 573.63K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 19.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 71.00K shares 10-Q · filed 2023-08-10 | 513.63K shares derived: sum of 3 quarters · filed 2023-08-10 | 916.75K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 51.94K shares 10-Q · filed 2023-05-15 | 494.56K shares derived: sum of 2 quarters · filed 2023-05-15 | 897.69K shares derived: sum of 3 quarters · filed 2023-05-15 | 1.09M shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | 442.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 845.75K shares derived: sum of 2 quarters · filed 2023-03-30 | 1.04M shares derived: sum of 3 quarters · filed 2023-03-30 | 1.10M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 403.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 592.91K shares derived: sum of 2 quarters · filed 2022-11-10 | 652.69K shares 10-Q · filed 2022-11-10 | 800.67K shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 189.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 249.56K shares 10-Q · filed 2022-08-11 | 397.55K shares derived: sum of 3 quarters · filed 2022-08-11 | 787.64K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 59.78K shares 10-Q · filed 2022-05-11 | 207.77K shares derived: sum of 2 quarters · filed 2022-05-11 | 597.86K shares derived: sum of 3 quarters · filed 2022-05-11 | |
| 2021-12-31 | 147.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 538.08K shares derived: sum of 2 quarters · filed 2022-03-30 | 1.19M shares 10-K · filed 2022-03-30 | |
| 2021-09-30 | 390.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 1.04M shares 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | 654.25K shares 10-Q · filed 2021-08-12 | |||
| 2020-09-30 | 616.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 721.87K shares 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 105.09K shares 10-Q · filed 2021-08-12 | |||
| 2017-03-31 | 29.39K shares 10-Q · filed 2017-05-09 | 7.87M shares derived: sum of 2 quarters · filed 2017-05-09 | 8.01M shares derived: sum of 3 quarters · filed 2017-05-09 | 8.49M shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 7.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | 7.98M shares derived: sum of 2 quarters · filed 2017-03-06 | 8.46M shares derived: sum of 3 quarters · filed 2017-03-06 | 8.99M shares 10-K · filed 2017-03-06 |
| 2016-09-30 | 139.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 624.73K shares derived: sum of 2 quarters · filed 2016-11-08 | 1.15M shares 10-Q · filed 2016-11-08 | 1.27M shares derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | 485.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 1.01M shares 10-Q · filed 2016-08-09 | 1.13M shares derived: sum of 3 quarters · filed 2016-08-09 | 1.16M shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 526.66K shares 10-Q · filed 2016-05-06 | 646.36K shares derived: sum of 2 quarters · filed 2016-05-06 | 675.87K shares derived: sum of 3 quarters · filed 2016-05-06 | 1.51M shares derived: sum of 4 quarters · filed 2016-05-06 |
| 2015-12-31 | 119.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 149.21K shares derived: sum of 2 quarters · filed 2016-03-14 | 987.61K shares derived: sum of 3 quarters · filed 2016-03-14 | 3.83M shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 29.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 867.91K shares derived: sum of 2 quarters · filed 2015-11-12 | 3.71M shares 10-Q · filed 2015-11-12 | 3.75M shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 838.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 3.68M shares 10-Q · filed 2015-08-12 | 3.72M shares derived: sum of 3 quarters · filed 2015-08-12 | 4.81M shares derived: sum of 4 quarters · filed 2015-08-12 |
| 2015-03-31 | 2.84M shares 10-Q · filed 2015-05-11 | 2.89M shares derived: sum of 2 quarters · filed 2015-05-11 | 3.97M shares derived: sum of 3 quarters · filed 2015-05-11 | |
| 2014-12-31 | 46.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | 1.13M shares derived: sum of 2 quarters · filed 2015-03-24 | 1.16M shares 10-K · filed 2015-03-24 | |
| 2014-09-30 | 1.08M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 1.12M shares 10-Q · filed 2014-10-31 | ||
| 2014-06-30 | 34.33K shares 10-Q · filed 2014-08-11 | |||
| 2013-12-31 | 23.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | 227.12K shares 10-K · filed 2014-03-26 | ||
| 2013-09-30 | 203.14K shares 10-Q · filed 2013-11-04 | |||
| 2012-12-31 | 236.73K shares 10-K · filed 2014-03-26 | |||
| 2011-12-31 | 31.00K shares 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |